Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 7, 2014, Pages

  Smith, Gordon I ^a   Reeds, Dominic N ^a   Okunade, Adewole L ^a   Patterson, Bruce W ^a   Mittendorfer, Bettina ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTRADIOL; FATTY ACID; GLUCOSE; INSULIN; PROGESTERONE; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FREE FATTY ACID APPEARANCE RATE; HUMAN; ISOTOPE LABELING; LIPID METABOLISM; OUTCOME ASSESSMENT; PHYSICAL PARAMETERS; POSTMENOPAUSE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SYSTEMIC THERAPY; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVAGINAL; BIOLOGICAL AVAILABILITY; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INSULIN; KINETICS; LIPID METABOLISM; LIPOPROTEINS, VLDL; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE; TESTOSTERONE; TRIGLYCERIDES;

EID: 84904061750     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4470     Document Type: Article

References (32)

1. Wang X, Magkos F, Mittendorfer B. Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J Clin Endocrinol Metab. 2011;96:885-893.
2. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
3. Erenus M, Kutlay K, Kutlay L, Pekin S. Comparison of the impact of oral versus transdermal estrogen on serum lipoproteins. Fertil Steril. 1994;61:300-302. (Pubitemid 24057265)
4. Persson L, Henriksson P, Westerlund E, Hovatta O, Angelin B, Rudling M. Endogenous estrogens lower plasma PCSK9 and LDL cholesterol but not Lp(a) or bile acid synthesis in women. Arterioscler Thromb Vasc Biol. 2012;32:810-814.
5. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril. 2001;75:898-915. (Pubitemid 32401667)
6. Wolfe BM, Huff MW. Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women. J Clin Invest. 1993;92:456-461. (Pubitemid 23209029)
7. Wolfe BM, Plunkett ER. Early effects of continuous low-dosage all-norgestrel administered alone or with estrogen. Maturitas. 1994;18:207-219. (Pubitemid 24095618)
8. Berglund L, Carlström K, Stege R, et al. Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males. J Clin Endocrinol Metab. 1996;81:2633-2637. (Pubitemid 26240289)
9. Giannoulis MG, Jackson N, Shojaee-Moradie F, Sonksen PH, Martin FC, Umpleby AM. Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: a randomised controlled trial. Growth Horm IGF Res. 2006;16:308-317. (Pubitemid 44793714)
10. Snyder PJ, Peachey H, Berlin JA, et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab. 2000;85:2670-2677. (Pubitemid 32269134)
11. Thompson PD, Cullinane EM, Sady SP, et al. Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA. 1989;261:1165-1168. (Pubitemid 19062451)
12. Singh AB, Hsia S, Alaupovic P, et al. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab. 2002;87:136-143. (Pubitemid 34084682)
13. Høst C, Gormsen LC, Christensen B, et al. Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study. Diabetes. 2013;62:1409-1416.
14. Wang X, Smith GI, Patterson BW, et al. Testosterone increases the muscle protein synthesis rate but does not affect very-low-density lipoprotein metabolism in obese premenopausal women. Am J Physiol Endocrinol Metab. 2012;302:E740-E746.
15. Somboonporn W, Davis S, Seif MW, Bell R. Testosterone for periand postmenopausal women. Cochrane Database Syst Rev. 2005;19:CD004509.
16. Zang H, Moritz T, Norstedt G, Hirschberg AL, Tollet-Egnell P. Effects of oestrogen and testosterone therapy on serum metabolites in postmenopausal women. Clin Endocrinol (Oxf). 2012;77:288-295.
17. Mittendorfer B, Patterson BW, Klein S. Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr. 2003;77:573-579. (Pubitemid 36258564)
18. Adiels M, Borén J, Caslake MJ, et al. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol. 2005;25:1697-1703. (Pubitemid 41098943)
19. Smith GI, Yoshino J, Reeds DN, et al. Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women. J Clin Endocrinol Metab. 2014;99:256-265.
20. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes. 2003;52:1641-1648. (Pubitemid 36792451)
21. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-1470. (Pubitemid 29418240)
22. Patterson BW, Mittendorfer B, Elias N, Satyanarayana R, Klein S. Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J Lipid Res. 2002;43:223-233. (Pubitemid 34184009)
23. Magkos F, Patterson BW, Mittendorfer B. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Am J Physiol Endocrinol Metab. 2006;291:E1243-E1249. (Pubitemid 44904031)
24. Magkos F, Patterson BW, Mohammed BS, Klein S, Mittendorfer B. Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J Clin Endocrinol Metab. 2007;92:1311-1318. (Pubitemid 46556403)
25. Marinou K, Adiels M, Hodson L, Frayn KN, Karpe F, Fielding BA. Youngwomenpartition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men. Br J Nutr. 2011;105:857-865.
26. Hodson L, Bickerton AS, McQuaid SE, et al. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state. Diabetes. 2007;56:2433-2441. (Pubitemid 47523250)
27. Gormsen LC, Jensen MD, Schmitz O, Møller N, Christiansen JS, Nielsen S. Energy expenditure, insulin, and VLDL-triglyceride production in humans. J Lipid Res. 2006;47:2325-2332. (Pubitemid 44936143)
28. Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106:15430-15435.
29. Koutsari C, Mundi MS, Ali AH, Patterson BW, Jensen MD. Systemic free fatty acid disposal into very low-density lipoprotein triglycerides. Diabetes. 2013;62:2386-2395.
30. Nielsen S, Karpe F. Determinants of VLDL-triglycerides production. Curr Opin Lipidol. 2012;23:321-326.
31. Tran C, Jacot-Descombes D, Lecoultre V, et al. Sex differences in lipid and glucose kinetics after ingestion of an acute oral fructose load. Br J Nutr. 2010;104:1139-1147.
32. Mittendorfer B, Patterson BW, Klein S, Sidossis LS. VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am J Physiol Endocrinol Metab. 2003;284:E708-E715. (Pubitemid 36323863)